title: Hypothesis: Can clofazimine prevent IRIS in HIV/TB co-infected individuals?
authors: Norman
authors: N
authors: Markowitz
authors: Upasna
authors: U
authors: Agarwal
authors: Dwayne
authors: D
authors: Baxa
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D044966:Anti-Retroviral Agents / Q000009:adverse effects; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002991:Clofazimine / Q000627:therapeutic use*; D060085:Coinfection; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000139:chemically induced / Q000517:prevention & control*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D044966:Anti-Retroviral Agents; D000995:Antitubercular Agents; D002991:Clofazimine